EPRX vs PRLD: stock comparison and AI forecast
Eupraxia Pharmaceuticals Inc. (EPRX) and Prelude Therapeutics Inc (PRLD) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
EPRX Eupraxia Pharmaceuticals Inc.
- Market Cap
- $435M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
PRLD Prelude Therapeutics Inc
- Market Cap
- $366M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- EPRX is 1.2 times larger than PRLD by market capitalization ($435M against $366M).
- PRLD carries 0.42 times debt per unit of equity, against 0.07 times for EPRX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | EPRX | PRLD |
|---|---|---|
| Market Cap | $435M | $366M |
| P/B Ratio | 5.30x | 2.74x |
| EPS | – | $-1.02 |
| Book Value/Share | $1.25 | $1.30 |
| Revenue/Share | – | $0.22 |
| FCF/Share | – | $-0.32 |
Profitability & Margins
| Metric | EPRX | PRLD |
|---|---|---|
| ROE | – | -45.2% |
| ROA | – | -31.9% |
| ROIC | – | -44.5% |
| Operating Margin | – | -300.6% |
| Net Margin | – | -269.8% |
| EBT Margin | – | -278.0% |
Financial Health
| Metric | EPRX | PRLD |
|---|---|---|
| Current Ratio | 15.12x | 4.07x |
| D/E Ratio | 0.07x | 0.42x |
| Financial Leverage | 1.05x | 1.42x |
| Working Capital | $79M | $117M |
Cash Flow
| Metric | EPRX | PRLD |
|---|---|---|
| Operating Cash Flow | – | -$33M |
| Free Cash Flow | – | -$33M |
| Capital Spending | – | $0.00M |
| FCF/Sales | – | -148.3% |
| CapEx/Sales | – | 0.0% |
Operational Efficiency
| Metric | EPRX | PRLD |
|---|---|---|
| Asset Turnover | – | 0.12x |
| Fixed Assets Turnover | – | 5.1x |
Income Statement
| Metric | EPRX | PRLD |
|---|---|---|
| Total Revenue | – | $22M |
| Operating Income | – | -$67M |
| Net Income | – | -$60M |
| R&D Expense | – | $69M |
Dividend & Shareholder Information
| Metric | EPRX | PRLD |
|---|---|---|
| Shares Outstanding | 66M | 103M |
EPRX vs PRLD: stock comparison and AI forecast
Which is bigger, EPRX or PRLD?
EPRX is 1.2 times larger than PRLD by market capitalization ($435M against $366M).
Which one does Intratio's AI model rank higher, EPRX or PRLD?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.